TP53 and hepatocellular carcinoma: It was found that patients negative for both p53 and cd133 expression in HCC have significantly better disease free-survival than those with only positive p53 expression (P < 0.001), only positive CD133 expression (P = 0.001), and both p53 and CD133 expression (P = 0.006).